This publication is a product of the HEALing Communities Study (HCS) and informed by the Communities That HEAL (CTH) Intervention Manual as well as integral contributions from research and community partners across four research sites. This guide was developed in recognition of the need to center community engagement throughout the efforts to address the opioid overdose crisis.

This guide was drawn from HEALing Communities Study (HCS) learnings to-date and expert insights to provide guidance regarding implementation of ORCCA menu strategies.

This guide examines the types of interventions that support successful reentry for adults with mental health conditions and/or substance use disorders who are leaving jail/prison.

This TIP supports learning about the key aspects, functions, and uses of Peer Support Services (PSS) in recovery from problematic substance use, which will help providers, supervisors, and administrators in SUD treatment programs better understand and respond to these changes.

Community engagement is often cited as a tool to improve the health of the community and its members. This guide will review evidence related to leveraging community engagement to support the implementation and scale-up of evidence-based programs and policies.

This guide focuses on research supporting adaptations of evidence-based practices (EBPs) for under-resourced populations. Adaptations involve tailoring care, programs, and services to the cultural, social, gender, and demographic contexts of the people served to yield positive outcomes.

This guide presents three evidence-based practices that engage and improve outcomes for individuals with concurrent substance use and concurrent substance use disorders.

This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.

This guide supports health care providers, systems, and communities seeking to prevent substance misuse among young adults. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.

This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment (MAT).

This guide explains how to use extended-release injectable naltrexone as part of medication-assisted treatment (MAT) for opioid use disorder.

This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts.

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

The National Practice Guideline (NPG) from the American Society of Addiction Medicine (ASAM) is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with opioid use disorder.

This manual provides guidelines for the operation of opioid treatment programs (OTPs). It covers patient assessment, treatment planning, and recovery care.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD

This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care among adult patients.

This guide equips clinicians with information for treating chronic pain in adults living with a history of substance use.

The AHRQ academy, which is a national resource for integrating behavioral health and primary care, offers guidance on how to integrate behavioral health and medication-assisted treatment for opioid use disorder into primary care or other ambulatory care settings to improve healthcare delivery and to achieve better patient outcomes.

This Guidance document gives a “bird’s eye view” of strategies to support best practice prescribing of antipsychotics for youth and summarizes the available evidence and principles to support these strategies.

This guide from the American Society of Addiction Medicine (ASAM) includes information on assessment, treatment overview (including treatment plans, patient participation, and counseling), and all the medications available to treat opioid use and overdose. It also provides links to find a provider and support groups for patients and families.

This National Practice Guideline (NPG) pocket guide from the American Society of Addiction Medicine (ASAM) is intended to aid clinicians in their clinical decision-making and patient management. The NPG pocket guide strives to identify and define clinical decision-making junctures that meet the needs of most patients in most circumstances.

This handbook provides guidance on using the web-based, multimedia tool Decisions in Recovery: Medications for Opioid Addiction.